These effects, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the strategy of focusing on ACKR3 as a unique solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Issues. In response to this https://elizabethm480xvt1.wikiusnews.com/user